To assess the differential expression of GPR4 across multiple cancers and their corresponding control (normal or non-tumor) tissues at the mRNA level, an integrated bioinformatics analysis were performed based on the omic tumor data set from the GEO database. This evidence concerns the gene GPR4 and cancer.